5.0
Aug 14, 2021
Recommend
CEO approval
Business Outlook
Pros
Changed somewhat after Roche bought out Genentech, Incentives weren’t as good, but still reasonable and appreciated.
Cons
No comment. I don’t have any comments I’d like to add or talk about in this section. Thank you!